Facebook
X
LinkedIn
ForwardHot Topics in Public Health: The Changing Vaccine Enterprise: Viewpoints of Wisconsin’s Former Advisory Committee on Immunization Practices Members - Enduring
Overview
The "Hot Topics in Public Health" symposium series is a forum designed to provide up-to-date information on emerging issues in public health. The series adopts various formats for education, including panel discussions, scholarly presentations, and audience-based question-and-answer sessions. Hot topics are selected by a steering committee of public health professionals, population health researchers, and clinicians at the University of Wisconsin School of Medicine and Public Health.
Welcome to the recording of our April 30, 2026 session. In this presentation, we explore how vaccine safety and effectiveness are assessed, as well as how evidence is translated into immunization recommendations. Presenters discuss the historical and current evidence‑to‑recommendation processes used by the U.S. Advisory Committee on Immunization Practices (ACIP), while examining how clinicians and public health entities apply these vaccine recommendations in practice.
Speakers Ed Belongia, MD, Paul Hunter, MD, and a representative from the Preventive Medicine Residency program each provide a 15–20 minute presentation, followed by a moderated Q&A. Viewers will gain valuable insight into the evolution of ACIP practices and learn where to locate key resources for immunization practice.
Elements of Competencies
American Board of Medical Specialties:
- Professionalism
- Patient-centered care
- Population Health
Interprofessional communication
- Values and ethics
- Teams and teamwork
Social Impact and Belonging
- Address Differences in Health Outcomes
- Engage in Self-reflection
Intended Audience
Physicians, physician assistants, nurses, and healthcare professionals.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will…
- Identify approaches used to assess vaccine safety and vaccine effectiveness
- Describe the evidence-to-recommendation process used historically by the U.S. Advisor Committee on Immunization Practices
- Explain the utilization of vaccine recommendations by clinicians and public health entities
- Contrast current ACIP practices with those in the past
- Locate resources that can be used for immunization practice
Course summary
- 1.00 AAPA Category 1 CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Topics | Speakers |
|---|---|
Welcome
| Jon Temte, MD, PhD Josh Hood, DO (Preventive Medicine Resident) |
Generation of Vaccine-Related Evidence
Types of evidence used by ACIP, especially efficacy/effectiveness/safety, including experience with the generation of VE estimates and how this has changed | Ed Belongia, MD |
Evidence to Recommendation Processes
Review of the evidence-based processes approved and used historically by ACIP in evidence-to-recommendation, and how this has changed | JonTemte, MD,PhD |
Translation and Implementation How clinicians and public health use ACIP recommendations and how this has changed | Paul Hunter, MD |
Panel Q&A
Combination of prepared questions and audience questions | Josh Hood moderates |
Presenters
Jonathan Temte, MD, PhD, Associate Dean for Public Health and Community Engagement
Ed Belongia, MD, Adjunct Professor, Marshfield Clinic Research Foundation
Paul Hunter, MD, Professor, Department of Family Medicine and Community Health
Moderated by Josh Hood, DO, 2nd Year Resident, Preventive Medicine Residency
Planners
Jonathan L. Temte, MD, PhD
Maureen Durkin, PhD, DrPH
Sheri Johnson, PhD
Parvathy Pillai, PhD, MPH
Patrick Remington, MD, MPH
Elizabeth Salisbury-Afshar, MD, MPH
Ajay Sethi, PhD, MHS
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
|---|---|---|---|
| Jonathan L. Temte, MD, PhD | Course Director/Presenter | bioMérieux (Grant / Contract) Quidel Corporation (Grant / Contract) | No |
| Maureen Durkin, PhD, DrPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Sheri Johnson, PhD | Planner | No relevant relationships with ineligible companies to disclose | No |
| Parvathy Pillai, PhD, MPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Patrick Remington, MD, MPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Elizabeth Salisbury-Afshar, MD, MPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Ajay Sethi, PhD, MHS | Planner | No relevant relationships with ineligible companies to disclose | No |
| Ed Belongia | Presenter | Moderna (Independent Contractor - Consultant) | No |
| Paul Hunter | Presenter | AstraZeneca (Stock) CSL (Seqirus) (Stock) GlaxoSmithKline (Stock) Johnson & Johnson Health Care Systems Inc. (Stock) •Merck (Stock) Moderna (Stock) Novartis (Stock) Pfizer (Stock) Zoetis (Stock) Catalent Pharma Solutions, LLC (Stock) Sanofi Pasteur Inc. (Stock) | No |
| Josh Hood, DO | Presenter | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation and Credit Designation Statements
| Accreditation Logos | Accreditation Statements |
|---|---|
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live in-person activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live in-person activity for a maximum of 1.00 ANCC contact hours.
 | American Academy of Physician Assistants (AAPA)The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.10 CEUs or 1.00 hours.
Available Credit
- 1.00 AAPA Category 1 CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Questions
Email [email protected].
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at [email protected]